Two Schemes Response in Multiple Myeloma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorHospital General de Mexico
About this trial
Retrospective study based on medical records of patients with multiple myeloma, eligible for stem cell transplantation, who received, first-line, the VTD or TD combination.
Eligibility criteria
Qualifiers
clinical records of patients who were considered eligible for transplant due to their functional status and who were given some treatment strategy comprising a combination of drugs.
Disqualifiers
Incomplete clinical records
Clinical records of patients who abandoned treatment or could not continue with the treatment due to economic or distance issues
Clinical records of patients who presented severe sepsis before the beginning of either treatment
Trial design
Treatments tested in this trial
- Bortezomib
Treatment groups
83 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov